1. Home
  2. GRNQ vs SILO Comparison

GRNQ vs SILO Comparison

Compare GRNQ & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenpro Capital Corp.

GRNQ

Greenpro Capital Corp.

HOLD

Current Price

$1.70

Market Cap

16.6M

Sector

Technology

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.39

Market Cap

4.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRNQ
SILO
Founded
2013
2010
Country
Malaysia
United States
Employees
N/A
N/A
Industry
EDP Services
Apparel
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
16.6M
4.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
GRNQ
SILO
Price
$1.70
$0.39
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
27.6K
185.4K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,110,208.00
$72,102.00
Revenue This Year
N/A
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.04
N/A
52 Week Low
$0.84
$0.33
52 Week High
$2.50
$3.37

Technical Indicators

Market Signals
Indicator
GRNQ
SILO
Relative Strength Index (RSI) 48.14 46.86
Support Level $1.67 $0.33
Resistance Level $1.75 $0.43
Average True Range (ATR) 0.08 0.03
MACD -0.01 0.00
Stochastic Oscillator 17.36 56.57

Price Performance

Historical Comparison
GRNQ
SILO

About GRNQ Greenpro Capital Corp.

Greenpro Capital Corp operates and provides business solution services to small and medium-sized businesses located in Southeast Asia and East Asia, with a focus on Hong Kong, China and Malaysia, and in Thailand and Taiwan. Its range of services includes cross-border business solutions, record management services, and accounting outsourcing services. Cross-border business services include other services, tax planning, trust and wealth management. Its segments include Service business engaged in the provision of corporate advisory and business solution services; Real estate business segment engaged in trading or leasing of commercial real estate properties in Hong Kong and Malaysia; and Digital business segment engaged in provision of digital platform and trading of digital assets.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: